Concepedia

Mark Biagi

MB

17

Publications

616

Citations

13

H-Index

2019

Active since

Affiliations

University of Illinois Chicago(Current)

University of Illinois Chicago, Rockford campus

Swedish American Hospital

Eugene Applebaum College of Pharmacy and Health Sciences

Wayne State University

Mark Biagi is an author at University of Illinois Chicago specializing in clinical microbiology, microbiology, and antibiotics.

ORCID

Top concepts

Publications per year

2019–2025

17

Publications

17

Development of High-Level Echinocandin Resistance in a Patient With Recurrent Candida auris Candidemia Secondary to Chronic Candiduria

Mark Biagi, Nathan P. Wiederhold, Connie Fe C. Gibas et al. · Open Forum Infectious Diseases · 2019 · 119 citations · Full text

Exploring Aztreonam in Combination with Ceftazidime-Avibactam or Meropenem-Vaborbactam as Potential Treatments for Metallo- and Serine-β-Lactamase-Producing <i>Enterobacteriaceae</i>

Mark Biagi, Ting Wu, Migyung Lee et al. · Antimicrobial Agents and Chemotherapy · 2019 · 97 citations · Full text

Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole

Mark Biagi, X. Tan, Tian-Shung Wu et al. · Journal of Clinical Microbiology · 2019 · 59 citations · Full text

Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia

Mark Biagi, A. Vialichka, M. Jurkovic et al. · Antimicrobial Agents and Chemotherapy · 2020 · 55 citations · Full text

Activity of Aztreonam in Combination with Avibactam, Clavulanate, Relebactam, and Vaborbactam against Multidrug-Resistant Stenotrophomonas maltophilia

Mark Biagi, D. Lamm, K. Meyer et al. · Antimicrobial Agents and Chemotherapy · 2020 · 44 citations · Full text

Rows per page

1–5 of 17